Author

D. Intartaglia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:zebrafish· 1

Frequent Co-Authors

I. Conte· 2 shared A. Colantuono· 1 shared A. M. Guarino· 1 shared A. Tito· 1 shared C. Wilson· 1 shared E. M. Pedone· 1 shared E. Polishchuk· 1 shared F. Apone· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

I. Conte

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyTrafficPeer-reviewedNov 14, 2023

Role of trafficking protein particle complex 2 in medaka development

M. A. De Matteis, F. Zappa, D. Intartaglia…·I. Conte

This study generates a medaka model for Spondyloepiphyseal Dysplasia Tarda by knocking out TRAPPC2, revealing developmental defects similar to human SEDT.

DOI 10.1111/tra.12924

zebrafishexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivDec 1, 2020

A pomegranate peel extract as inhibitor of SARS-CoV-2 Spike binding to human ACE2 (in vitro): a promising source of novel antiviral drugs

A. Tito, A. Colantuono, L. Pirone…·F. Apone

This study shows that pomegranate peel extract inhibits SARS-CoV-2 Spike binding to ACE2 and 3CL protease activity in vitro, suggesting potential as an antiviral agent.

DOI 10.3389/fchem.2021.638187

humanexperimental assay

𝕏 PostBluesky